[1] Ahrens E T, Flores R, Xu H Y, et al. In vivo imaging platform for tracking immunotherapeutic cells[J]. Nature Biotechnology, 2005, 23(8):983-987.
[2] Chen H, Song M, Tang J, et al. Ultrahigh 19F loaded Cu1.75S nanoprobes for simultaneous 19F magnetic resonance imaging and photothermal therapy[J]. ACS Nano, 2016, 10(1):1355-1362.
[3] Tatsuya N, Hisashi M, Fuminori S, et al. Activatable (19) F MRI nanoparticle probes for the detection of reducing environments[J]. Angewandte Chemie, International Edition in English, 2015, 127(3):1021-1024.
[4] Lauterbur P C. Image formation by induced local interactions. Examples employing nuclear magnetic resonance. 1973[J]. Nature, 1973, 242(5394):190-191.
[5] Debbage P, Jaschke W. Molecular imaging with nanoparticles:giant roles for dwarf actors[J]. Histochemistry and Cell Biology, 2008, 130(5):845-875.
[6] Villaraza A J L, Bumb A, Brechbiel M W. Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging:the interplay between size, function, and pharmacokinetics[J]. Chemical Reviews, 2010, 110(5):2921-2959.
[7] Yu L, Huang D Y, Yousaf M Z, et al. Magnetic nanoparticle-based cancer therapy[J]. Chinese Physics B, 2013, 22(2):23-35.
[8] Ilaria T, Valentina D, Claudia P, et al. (19)F magnetic resonance imaging (MRI):from design of materials to clinical applications[J]. Chemical Reviews, 2015, 115(2):1106-1129.
[9] Klass S H, Truxal A E, Fiala T A, et al. Rotaxane probes for the detection of hydrogen peroxide by 129Xe hyperCEST NMR spectroscopy[J]. Angewandte Chemie-International Edition, 2019, 58(29):9948-9953.
[10] Kanda T, Fukusato T, Matsuda M, et al. Gadolinium-based contrast agent accumulates in the brain even in subjects without severe renal dysfunction:evaluation of autopsy brain specimens with inductively coupled plasma mass spectroscopy[J]. Radiology, 2015, 276(1):228-232.
[11] Knight J C, Edwards P G, Paisey S J. Fluorinated contrast agents for magnetic resonance imaging; a review of recent developments[J]. RSC Advances, 2011, 1(8):1415-1425.
[12] Ruiz-Cabello J, Barnett B P, Bottomley P A, et al. Fluorine (F-19) MRS and MRI in biomedicine[J]. NMR in Biomedicine, 2011, 24(2):114-129.
[13] Shan L, Chopra A, Leung K, et al. Characterization of na-noparticle-based contrast agents for molecular magnetic resonance imaging[J]. Journal of Nanoparticle Research, 2012, 14(9):1-12.
[14] Ashur I, Allouche-Arnon H, Bar-Shir A. Calcium fluoride nanocrystals:tracers for in vivo F-19 magnetic resonance imaging[J]. Angewandte Chemie-International Edition, 2018, 57(25):7478-7482.
[15] Hui P, Idriss B, Bronwin D, et al. Synthesis and evaluation of partly fluorinated block copolymers as MRI imaging agents[J]. Biomacromolecules, 2009, 10(2):374-381.
[16] Neubauer A M, Jacob M, Caruthers S D, et al. Gadolinium-modulated 19F signals from perfluorocarbon nanoparticles as a new strategy for molecular imaging[J]. Magnetic Resonance in Medicine, 2010, 60(5):1066-1072.
[17] Bartusik D, Tomanek B. Detection of 19 F-labeled biopharmaceuticals in cell cultures with magnetic resonance[J]. Advanced Drug Delivery Reviews, 2013, 65(8):1056-1064.
[18] Kislukhin A A, Xu H, Adams S R, et al. Paramagnetic fluorinated nanoemulsions for sensitive cellular fluorine-19 magnetic resonance imaging[J]. Nature Materials, 2016, 15(6):662-668.
[19] Krafft M P. Fluorocarbons and fluorinated amphiphiles in drug delivery and biomedical research[J]. Advanced Drug Delivery Reviews, 2001, 47(2):209-228.
[20] Guo C, Xu M M, Xu S Y, et al. Multifunctional nanoprobes for both fluorescence and F-19 magnetic resonance imaging[J]. Nanoscale, 2017, 9(21):7163-7168.
[21] Tirotta I, Mastropietro A, Cordiglieri C, et al. A super- fluorinated molecular probe for highly sensitive in vivo(19)F-MRI[J]. Journal of the American Chemical Society, 2014, 136(24):8524-8527.
[22] Ruiz-Cabello J, Walczak P, Kedziorek D A, et al. In vivo "hot spot" MR imaging of neural stem cells using fluorinated nanoparticles[J]. Magnetic Resonance in Medicine, 2008, 60(6):1506-1511.
[23] Ahrens E T, Bulte J W M. Tracking immune cells in vivo using magnetic resonance imaging[J]. Nature Reviews Immunology, 2013, 13(10):755-763.
[24] Kaneda M M, Caruthers S, Lanza G M, et al. Perfluorocarbon nanoemulsions for quantitative molecular imaging and targeted therapeutics[J]. Annals of Biomedical Enginee-ring, 2009, 37(10):1922-1933.
[25] Ratner A V, Hurd R, Muller H H, et al. 19F magnetic re-sonance imaging of the reticuloendothelial system[J]. Magnetic Resonance in Medicine, 2010, 5(6):548-554.
[26] Janjic J M, Srinivas M, Kadayakkara D K K, et al. Self-delivering nanoemulsions for dual fluorine-19 MRI and fluorescence detection[J]. Journal of the American Chemical Society, 2008, 130(9):2832-2841.
[27] Janjic J M, Ahrens E T. Fluorine-containing nanoemulsions for MRI cell tracking[J]. Wiley Interdisciplinary Reviews:Nanomedicine and Nanobiotechnology,2010,1(5):492-501.
[28] Pisani E, Tsapis N, Galaz B, et al. Perfluorooctyl bromide polymeric capsules as dual contrast agents for ultrasonography and magnetic resonance imaging[J]. Advanced Functio-nal Materials, 2010, 18(19):2963-2971.
[29] Balducci A, Wen Y, Zhang Y, et al. A novel probe for the non-invasive detection of tumor-associated inflammation[J]. Oncoimmunology, 2013, 2(2):e23034.
[30] Mangala S, Cruz L J, Fernando B, et al. Customizable, multi-functional fluorocarbon nanoparticles for quantitative in vivo imaging using 19F MRI and optical imaging[J]. Biomaterials, 2010, 31(27):7070-7077.
[31] Yingli F, Nicole A, Tina E, et al. Fused X-ray and MR imaging guidance of intrapericardial delivery of microencapsulated human mesenchymal stem cells in immunocompetent swine[J]. Radiology, 2014, 272(2):427-437.
[32] Kedziorek D A, Solaiyappan M, Walczak P, et al. Using C-arm X-ray imaging to guide local reporter probe delivery for tracking stem cell engraftment[J]. Theranostics, 2013, 3(11):916-926.
[33] T Kevin H, Qing Y, Eytan D F, et al. 19F MRI detection of acute allograft rejection with in vivo perfluorocarbon labeling of immune cells[J]. Magnetic Resonance in Medicine, 2011, 65(4):1144-1153.
[34] Ahrens E T, Helfer B M, O'Hanlon C F, et al. Clinical cell therapy imaging using a perfluorocarbon tracer and fluorine-19 MRI[J]. Magnetic Resonance in Medicine Official Journal of the Society of Magnetic Resonance in Medicine, 2015, 72(6):1696-1701.
[35] Rose L C, Kadayakkara D K, Wang G, et al. Fluorine-19 labeling of stromal vascular fraction cells for clinical imaging applications[J]. Stem Cells Translational Medicine, 2016, 4(12):1472-1481.
[36] Boehm-Sturm P, Mengler L, Wecker S, et al. In vivo trac-king of human neural stem cells with 19F Magnetic resonance imaging[J]. PloS One, 2011, 6(12):e29040.
[37] Fu Y, Weiss C R, Kedziorek D A, et al. Noninvasive monitoring of allogeneic stem cell delivery with dual-modality imaging-visible microcapsules in a rabbit model of peripheral arterial disease[J]. Stem Cells International, 2019, 2019:10.
[38] Nöth U, Morrissey S P, Deichmann R, et al. Perfluoro-15-crown-5-ether labelled macrophages in adoptive transfer experimental allergic encephalomyelitis[J]. Artificial Cells, Blood Substitutes, and Immobilization Biotechnology, 1997, 25(3):243-254.
[39] Guo C, Zhang Y, Li Y, et al. 19F MRI nanoprobes for the turn-on detection of phospholipase A2 with a low background[J]. Analytical Chemistry, 2019, 91(13):8147-8153.
[40] Lionel M, Julie M, Olivier S, et al. Hexafluorobenzene in comparison with perfluoro-15-crown-5-ether for repeated monitoring of oxygenation using 19F MRI in a mouse model[J]. Magnetic Resonance in Medicine, 2013, 69(1):248-254.
[41] Bartusik D, Tomanek B, Siluk D, et al. F MRI of 3D CEM cells to study the effects of tocopherols and tocotrienols[J]. Journal of Pharmaceutical and Biomedical Analysis, 2010, 53(3):599-602.
[42] Gulyaev M V, Kuznetsova A V, Silachev D N, et al. Realization of 19F MRI oximetry method using perfluorodecalin[J]. Magnetic Resonance Materials in Physics, Biology and Medicine, 2019, 32(1):307-315.
[43] Christoph J, Sebastian T, Friederike M, et al. Probing different perfluorocarbons for in vivo inflammation imaging by 19F MRI:image reconstruction, biological half-lives and sensitivity[J]. NMR in Biomedicine, 2014, 27(3):261-271.
[44] Schwarz R, Kaspar A, Seelig J, et al. Gastrointestinal transit times in mice and humans measured with Al-27 and F-19 nuclear magnetic resonance[J]. Magnetic Resonance in Medicine, 2002, 48(2):255-261.
[45] Fernando B, Mangala S, Arend H, et al. A novel (19)F agent for detection and quantification of human dendritic cells using magnetic resonance imaging[J]. International Journal of Cancer, 2011, 129(2):365-373.
[46] Kuznetsova I N. Perfluorocarbon emulsions:stability in vitro and in vivo (a review)[J]. Pharmaceutical Chemistry Journal, 2003, 37(8):415-420.
[47] Zhang C, Moonshi S S, Wang W, et al. High F-content perfluoropolyether-based nanoparticles for targeted detection of breast cancer by 19F magnetic resonance and optical imaging[J]. ACS Nano, 2018, 12(9):9162-9176.
[48] Thurecht K J, Blakey I, Peng H, et al. Functional hyperbranched polymers:toward targeted in vivo 19f magnetic re-sonance imaging using designed macromolecules[J]. Journal of the American Chemical Society, 2010, 132(15):5336-5337.
[49] Jiang Z X, Xin L, Eun-Kee J, et al. Symmetry-guided design and fluorous synthesis of a stable and rapidly excreted imaging tracer for (19)F MRI[J]. Angewandte Chemie, 2010, 48(26):4755-4758.
[50] Cruz L J, Que I, Aswendt M, et al. Targeted nanoparticles for the non-invasive detection of traumatic brain injury by optical imaging and fluorine magnetic resonance imaging[J]. Nano Research, 2016, 9(5):1276-1289.
[51] Guo Z, Gao M, Song M, et al. Superfluorinated PEI derivative coupled with (99m) Tc for ASGPR targeted (19) F MRI/SPECT/PA tri-modality imaging[J]. Advanced Materials, 2016, 28(28):5898-5906.
[52] Wang K, Peng H, Thurecht K J, et al. Fluorinated POSS-Star Polymers for 19F MRI[J]. Macromolecular Chemistry and Physics, 2016, 217(20):2262-2274.
[53] Wallat J D, Czapar A E, Wang C, et al. Optical and magne-tic resonance imaging using fluorous colloidal nanoparticles[J]. Biomacromolecules, 2017, 18(1):103-112.
[54] Moonshi S S, Zhang C, Peng H, et al. A unique 19F MRI agent for the tracking of non phagocytic cells in vivo[J]. Nanoscale, 2018, 10(17):8226-8239.
[55] Wang K, Peng H, Thurecht K J, et al. Multifunctional hyperbranched polymers for CT/19F MRI bimodal molecular imaging[J]. Polymer Chemistry, 2016, 7(5):1059-1069.
[56] Wang Z, Yue X, Wang Y, et al. A symmetrical fluorous dendron-cyanine dye-conjugated bimodal nanoprobe for quantitative 19F MRI and NIR fluorescence bioimaging[J]. Advanced Healthcare Materials, 2015, 3(8):1326-1333.
[57] Lammers T, Mertens M E, Schuster P, et al. Fluorinated polyurethane scaffolds for (19)F magnetic resonance imaging[J]. Chemistry of Materials, 2017, 29(7):2669-2671.
[58] Fu C, Herbst S, Zhang C, et al. Polymeric 19F MRI agents responsive to reactive oxygen species[J]. Polymer Chemistry, 2017, 8(31):4585-4595.
[59] Huang P, Guo W, Yang G, et al. Fluorine meets amine:reducing microenvironment-induced amino-activatable nanoprobes for 19F magnetic resonance imaging of bio-thiols[J]. ACS Applied Materials & Interfaces, 2018, 10(22):18532-18542.
[60] Marbella L E, Millstone J E. NMR techniques for noble me-tal nanoparticles[J]. Chemistry of Materials, 2015, 27(8):2721-2739.
[61] Yadong Y, A Paul A. Colloidal nanocrystal synthesis and the organic-inorganic interface[J]. Nature, 2005, 437(7059):664-670.
[62] Rabin O, Perez J M, Grimm J, et al. An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles[J]. Nature Materials, 2006, 5(2):118-122.
[63] Du Y P, Sun X, Zhang Y W, et al. Uniform alkaline earth fluoride nanocrystals with diverse shapes grown from thermolysis of metal trifluoroacetates in hot surfactant solutions[J]. Crystal Growth & Design, 2009, 9(4):2013-2019. |